AEG, BRK.A And MMC, 3 Financial Stocks Pushing The Sector Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 17 points (-0.1%) at 17,039 as of Tuesday, July 15, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 915 issues advancing vs. 2,069 declining with 174 unchanged.

The Financial sector currently sits down 0.2% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the sector include Charles Schwab ( SCHW), down 1.3%, and American Tower ( AMT), down 0.9%. Top gainers within the sector include Woori Finance Holdings ( WF), up 3.4%, Royal Bank of Scotland Group (The ( RBS), up 2.9%, Orix ( IX), up 2.2%, Deutsche Bank ( DB), up 1.6% and MasterCard ( MA), up 1.1%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. Aegon ( AEG) is one of the companies pushing the Financial sector lower today. As of noon trading, Aegon is down $0.10 (-1.2%) to $8.63 on average volume. Thus far, 545,883 shares of Aegon exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $8.58-$8.70 after having opened the day at $8.66 as compared to the previous trading day's close of $8.73.

Aegon N.V. provides life insurance, pension, and asset management products and services. Aegon has a market cap of $21.6 billion and is part of the insurance industry. Shares are down 7.9% year-to-date as of the close of trading on Monday. Currently there is 1 analyst that rates Aegon a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Aegon as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, good cash flow from operations, increase in stock price during the past year, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aegon Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Berkshire Hathaway ( BRK.A) is down $1,181.00 (-0.6%) to $192,199.00 on average volume. Thus far, 118 shares of Berkshire Hathaway exchanged hands as compared to its average daily volume of 300 shares. The stock has ranged in price between $192,000.01-$193,750.00 after having opened the day at $193,480.00 as compared to the previous trading day's close of $193,380.00.

Berkshire Hathaway, Inc. is a publicly owned investment manager. Through its subsidiaries, the firm primarily engages in the insurance and reinsurance of property and casualty risks business. Berkshire Hathaway was founded in 1889 and is based in Omaha, Nebraska. Berkshire Hathaway has a market cap of $165.2 billion and is part of the insurance industry. Shares are up 8.7% year-to-date as of the close of trading on Monday.

TheStreet Ratings rates Berkshire Hathaway as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Berkshire Hathaway Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Marsh & McLennan Companies ( MMC) is down $0.54 (-1.0%) to $51.78 on heavy volume. Thus far, 2.1 million shares of Marsh & McLennan Companies exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $51.69-$52.16 after having opened the day at $52.08 as compared to the previous trading day's close of $52.32.

Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions primarily in the areas of risk, strategy, and human capital worldwide. It operates in two segments, Risk and Insurance Services and Consulting. Marsh & McLennan Companies has a market cap of $28.7 billion and is part of the insurance industry. Shares are up 8.2% year-to-date as of the close of trading on Monday. Currently there are 11 analysts that rate Marsh & McLennan Companies a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Marsh & McLennan Companies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Marsh & McLennan Companies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the financial sector could consider Financial Select Sector SPDR ( XLF) while those bearish on the financial sector could consider Proshares Short Financials ( SEF).

null

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug